Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13G/A for Invivyd, Inc. Common Stock, $0.0001 par value per share (IVVD).
- Disclosed ownership: 9%.
- Date of event: 31 Dec 2025.
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 9% ownership in Invivyd, Inc. Common Stock, $0.0001 par value per share (IVVD) on 31 Dec 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 4.9% | 13,619,218 | 0 | 13,619,218 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF I GP LLC | 4.9% | 13,619,218 | 0 | 13,619,218 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BIOTECHNOLOGY VALUE FUND II LP | 3.6% | 9,954,397 | 0 | 9,954,397 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF II GP LLC | 3.6% | 9,954,397 | 0 | 9,954,397 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| Biotechnology Value Trading Fund OS LP | 0.6% | 1,563,852 | 0 | 1,563,852 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF Partners OS Ltd. | 0.6% | 1,563,852 | 0 | 1,563,852 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF GP HOLDINGS LLC | 8.3% | 23,573,615 | 0 | 23,573,615 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF PARTNERS L P/IL | 9% | 25,525,000 | 0 | 25,525,000 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF INC/IL | 9% | 25,525,000 | 0 | 25,525,000 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| LAMPERT MARK N | 9% | 25,525,000 | 0 | 25,525,000 | /s/ Mark N. Lampert | Mark N. Lampert |